Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii

寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制

基本信息

项目摘要

Reactivation of chronic Toxoplasma gondii infection causes ocular, cardiac, respiratory, and neurologic disease in immune-deficient individuals. Current treatments fail to eliminate the slow replicating, persistent Toxoplasma bradyzoite cysts that seed reactivation and disease, which manifests most severely as Toxoplasmic encephalitis. Our long-term goal is to identify critical liabilities for disrupting Toxoplasma persistence, thereby eliminating the risk of potentially fatal Toxoplasmic encephalitis in at-risk individuals. Toward this goal, we have recently demonstrated that the viability of bradyzoite cysts in culture and in infected mice critically relies on the parasite having a functional autophagy pathway based on targeted disruption of TgATG9. TgATG9 deficient bradyzoites show markedly reduced autophagy and severe loss of viability in culture and in experimentally infected mice. Since autophagy is necessary for cellular homeostasis, our findings support a new concept of disrupting parasite homeostasis to quell infection. However, little is known about autophagy in Toxoplasma and pursuing this concept requires identifying new and divergent components in the pathway. To meet this need, we will discover novel early components of the autophagy pathway, define how they cooperatively mediate the development of autophagic structures, and determine their contributions to parasite persistence in vitro and in vivo. Completing the proposed studies will provide proof-of-concept that targeting parasite homeostasis is an effective strategy to disrupt persistence.
慢性弓形虫感染的再激活可引起免疫缺陷个体的眼部、心脏、呼吸道和神经系统疾病。目前的治疗方法不能消除缓慢复制的、持久的弓形虫缓殖子包囊,这些包囊导致再活化和疾病,最严重的表现为弓形虫脑炎。我们的长期目标是确定破坏弓形虫持久性的关键责任,从而消除高危人群中潜在致命性弓形虫脑炎的风险。为了实现这一目标,我们最近已经证明,培养和感染小鼠中的缓殖子包囊的生存能力严重依赖于寄生虫具有基于TgATG 9的靶向破坏的功能性自噬途径。TgATG9缺陷的缓殖子在培养物和实验感染的小鼠中显示出显著减少的自噬和严重的生存能力丧失。由于自噬是细胞稳态所必需的,我们的研究结果支持了一个新的概念,破坏寄生虫的稳态,以平息感染。然而,对弓形虫中的自噬知之甚少,追求这一概念需要识别途径中新的和不同的组分。为了满足这一需求,我们将发现新的自噬途径的早期组件,定义它们如何协同介导自噬结构的发展,并确定它们在体外和体内对寄生虫持久性的贡献。完成拟议的研究将提供概念验证,即靶向寄生虫体内平衡是破坏持久性的有效策略。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.
  • DOI:
    10.1017/s003118201800001x
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Di Cristina M;Carruthers VB
  • 通讯作者:
    Carruthers VB
Structural Features of Apicomplexan Pore-Forming Proteins and Their Roles in Parasite Cell Traversal and Egress.
  • DOI:
    10.3390/toxins9090265
  • 发表时间:
    2017-08-29
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Guerra AJ;Carruthers VB
  • 通讯作者:
    Carruthers VB
Toxoplasma Retromer Is Here to Stay.
  • DOI:
    10.1016/j.pt.2016.05.007
  • 发表时间:
    2016-10
  • 期刊:
  • 影响因子:
    9.6
  • 作者:
    McGovern OL;Carruthers VB
  • 通讯作者:
    Carruthers VB
The vacuolar iron transporter mediates iron detoxification in Toxoplasma gondii.
  • DOI:
    10.1038/s41467-023-39436-y
  • 发表时间:
    2023-06-20
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Aghabi, Dana;Sloan, Megan;Gill, Grace;Hartmann, Elena;Antipova, Olga;Dou, Zhicheng;Guerra, Alfredo J.;Carruthers, Vern B.;Harding, Clare R.
  • 通讯作者:
    Harding, Clare R.
An Uninvited Seat at the Dinner Table: How Apicomplexan Parasites Scavenge Nutrients from the Host.
  • DOI:
    10.3390/microorganisms9122592
  • 发表时间:
    2021-12-15
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Piro F;Focaia R;Dou Z;Masci S;Smith D;Di Cristina M
  • 通讯作者:
    Di Cristina M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vernon Bruce Carruthers其他文献

Vernon Bruce Carruthers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vernon Bruce Carruthers', 18)}}的其他基金

Identifying novel players in Toxoplasma autophagy during chronic infection”
识别慢性感染期间弓形虫自噬的新参与者 –
  • 批准号:
    10223735
  • 财政年份:
    2021
  • 资助金额:
    $ 44.27万
  • 项目类别:
Identifying novel players in Toxoplasma autophagy during chronic infection”
识别慢性感染期间弓形虫自噬的新参与者 –
  • 批准号:
    10372165
  • 财政年份:
    2021
  • 资助金额:
    $ 44.27万
  • 项目类别:
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis
中枢神经系统渗透性组织蛋白酶 L 抑制剂治疗慢性弓形虫病的合理设计
  • 批准号:
    9813831
  • 财政年份:
    2016
  • 资助金额:
    $ 44.27万
  • 项目类别:
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii
寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制
  • 批准号:
    10296195
  • 财政年份:
    2015
  • 资助金额:
    $ 44.27万
  • 项目类别:
T. GONDII CHLOROQUINE RESISTANCE TRANSPORTER AND REDOX
弓形虫氯喹抗性转运蛋白和氧化还原
  • 批准号:
    8938727
  • 财政年份:
    2015
  • 资助金额:
    $ 44.27万
  • 项目类别:
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii
寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制
  • 批准号:
    10461953
  • 财政年份:
    2015
  • 资助金额:
    $ 44.27万
  • 项目类别:
Toxoplasma endocytosis of host cytoplasm
弓形虫对宿主细胞质的内吞作用
  • 批准号:
    8604674
  • 财政年份:
    2013
  • 资助金额:
    $ 44.27万
  • 项目类别:
Toxoplasma endocytosis of host cytoplasm
弓形虫对宿主细胞质的内吞作用
  • 批准号:
    8445544
  • 财政年份:
    2013
  • 资助金额:
    $ 44.27万
  • 项目类别:
Proteolytic modulation of toxoplasma invasion proteins
弓形虫入侵蛋白的蛋白水解调节
  • 批准号:
    8384858
  • 财政年份:
    2008
  • 资助金额:
    $ 44.27万
  • 项目类别:
Proteolytic modulation of toxoplasma invasion proteins
弓形虫入侵蛋白的蛋白水解调节
  • 批准号:
    7579559
  • 财政年份:
    2008
  • 资助金额:
    $ 44.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了